At the protein level, high CD99 expression has been observed in Ewing sarcoma, lymphoblastic lymphoma and malignant glioma whereas liver cancer and pancreatic cancer represent a smaller group with low CD99 expression [34]. This evidence concerns the gene CD99 and lymphoblastic lymphoma.